Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells

World Journal of Surgical Oncology

Volumn 10, Issue , 2012, Pages

  Zhu, Zhitu ^a   Li, Enze ^a   Liu, Yangyang ^a   Gao, Yu ^a   Sun, Hongzhi ^a   Ma, Guangyou ^a   Wang, Zhenghua ^a   Liu, Xiaomei ^a   Wang, Qingjun ^a   Qu, Xiujuan ^b   Liu, Yunpeng ^b   Yu, Yunlong ^c  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c CNOOC RESEARCH INSTITUTE   (China)

Author keywords

Apoptosis; Bufalin; Caspase; Colon cancer; Jak stat3; Livin; M phase arrest

Indexed keywords

BUFALIN; CASPASE 3; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN BAX; PROTEIN BCL 2; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLOTTING, WESTERN; BUFANOLIDES; CELL CYCLE; CELL PROLIFERATION; COLONIC NEOPLASMS; ENZYME INHIBITORS; HUMANS; JANUS KINASE 1; MITOTIC INDEX; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 84867900932     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-10-228     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249. 10.3322/caac.20006, 19474385.
2. Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, André T, Chan E, Lordick F, Punt CJ, Strickland AH, Wilson G, Ciuleanu TE, Roman L, Van Cutsem E, Tzekova V, Collins S, Oliner KS, Rong A, Gansert J. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol 2010, 28:4706-4713. 10.1200/JCO.2009.27.6055, 20921462.
3. Krenn L, Kopp B. Bufadienolides from animal and plant sources. Phytochemistry 1998, 48:1-29. 10.1016/S0031-9422(97)00426-3, 9621450.
4. Cao-Hong, Shibayama-Imazu T, Masuda Y, Shinki T, Nakajo S, Nakaya K. Involvement of Tiam1 in apoptosis induced by bufalin in HeLa cells. Anticancer Res 2007, 27:245-249.
5. Tian X, Wang PP, Liu YP, Hou KZ, Jin B, Luo Y, Qu XJ. Effect of bufalin-inducing apoptosis on Bcl-2 and PKC in HL-60 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2007, 15:67-71.
6. Liu Y, Qu X, Wang P, Tian X, Luo Y, Liu S, Lu X. WT1 downregulation during K562 cell differentiation and apoptosis induced by bufalin. Zhonghua Xue Ye Xue Za Zhi 2002, 23:356-359.
7. Tian X, Luo Y, Liu YP, Hou KZ, Jin B, Zhang JD, Wang S. Downregulation of Bcl-2 and survivin expression and release of Smac/DIABLO involved in bufalin-induced HL-60 cell apoptosis. Zhonghua Xue Ye Xue Za Zhi 2006, 27:21-24.
8. Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem 1996, 271:14067-14072. 10.1074/jbc.271.24.14067, 8662906.
9. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship. Ann NY Acad Sci 2009, 1171:59-76. 10.1111/j.1749-6632.2009.04911.x, 3141289, 19723038.
10. Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 2007, 13:1362-1366. 10.1158/1078-0432.CCR-06-2313, 17332277.
11. Scheper MA, Nikitakis NG, Sauk JJ. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. Int J Oral Maxillofac Surg 2007, 36:632-639. 10.1016/j.ijom.2007.04.003, 17566705.
12. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004, 23:4921-4929. 10.1038/sj.onc.1207606, 15077160.
13. Haura EB, Turkson J, Jove R. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2005, 2:315-324.
14. Kawazoe N, Watabe M, Masuda Y, Nakajo S, Nakaya K. Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene 1999, 18:2413-2421. 10.1038/sj.onc.1202555, 10229192.
15. Chen A, Yu J, Zhang L, Sun Y, Zhang Y, Guo H, Zhou Y, Mitchelson K, Cheng J. Microarray and biochemical analysis of bufalin-induced apoptosis of HL-60 Cells. BiotechnolLett 2009, 31:487-494.
16. Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med 2008, 21:637-643.
17. Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng Y, Zhang J, Liu Y. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs 2009, 20:59-64. 10.1097/CAD.0b013e3283160fd6, 19343001.
18. Xie CM, Chan WY, Yu S, Zhao J, Cheng CH. Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radic Biol Med 2011, 51:1365-1375. 10.1016/j.freeradbiomed.2011.06.016, 21763418.
19. Jing Y, Watabe M, Hashimoto S, Nakajo S, Nakaya K. Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells. Anticancer Res 1994, 14:1193-2008.
20. Watabe M, Ito K, Masuda Y, Nakajo S, Nakaya K. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 1998, 16:779-787. 10.1038/sj.onc.1201592, 9488042.
21. Sun Y, Lin Y, Li H, Liu J, Sheng X, Zhang W. 2,5-Hexanedione induces human ovarian granulosa cell apoptosis through BCL-2, BAX, and CASPASE-3 signaling pathways. Arch Toxicol 2012, 86:205-215. 10.1007/s00204-011-0745-7, 21901545.
22. Yan B. Research progress on Livin protein: an inhibitor of apoptosis. Mol Cell Biochem 2011, 357:39-45. 10.1007/s11010-011-0873-7, 21617971.
23. Kitamura H, Honma I, Torigoe T, Hariu H, Asanuma H, Hirohashi Y, Sato E, Sato N, Tsukamoto T. Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients. Urology 2007, 70:38-42.
24. Chang H, Schimmer AD. Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol Cancer Ther 2007, 6:24-30. 10.1158/1535-7163.MCT-06-0443, 17237263.
25. Wang Q, Huang Y, Ni Y, Wang H, Hou Y. siRNA targeting midkine inhibits gastric cancer cells growth and induces apoptosis involved caspase-3,8,9 activation and mitochondrial depolarization. J Biomed Sci 2007, 14:783-795. 10.1007/s11373-007-9192-0, 17665317.
26. Pedranzini L, Dechow T, Berishaj M, Comenzo R, Zhou P, Azare J, Bornmann W, Bromberg J. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells. Cancer Res 2006, 66:9714-9721. 10.1158/0008-5472.CAN-05-4280, 17018630.
27. Yao X, Zhu F, Zhao Z, Liu C, Luo L, Yin Z. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway. J Cell Biochem 2011, 112:2837-2849. 10.1002/jcb.23198, 21608020.
28. Wang Z, Jin H, Xu R, Mei Q, Fan D. Triptolidedownregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med 2009, 41:717-727. 10.3858/emm.2009.41.10.078, 2772974, 19561401.
29. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Inoue K, Nagayasu T, Sekine I. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep 2006, 15:1445-1451.
30. Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J. STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells. Cancer Res 2011, 71:7226-7237. 10.1158/0008-5472.CAN-10-4660, 21900397.
31. Xi RC, Biao WS, Gang ZZ. Significant elevation of survivin and livin expression in human colorectal cancer: inverse correlation between expression and overall survival. Onkologie 2011, 34:428-432. 10.1159/000331132, 21934342.